Efficacy of intermittent androgen deprivation therapy vs conventional continuous androgen deprivation therapy for advanced prostate cancer: a meta-analysis

Efficacy of intermittent androgen deprivation therapy vs conventional continuous androgen deprivation therapy for advanced prostate cancer: a meta-analysis

Item
http://www.wikidata.org/entity/Q34133868
Conversion to monotherapy with luteinizing-hormone releasing hormone agonist or orchiectomy after reaching PSA nadir following maximal androgen blockade is able to prolong progression-free survival in patients with metastatic prostate cancer: A propGrowth of LAPC4 prostate cancer xenograft tumor is insensitive to 5α-reductase inhibitor dutasteride.Adoption of Intermittent Androgen Deprivation Therapy for Advanced Prostate Cancer: A Population Based Study in American Urology Practice.Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis.Unrecognized kinetics of serum testosterone: impact on short-term androgen deprivation therapy for prostate cancer.Intermittent androgen deprivation therapy in advanced prostate cancer.Adverse effects of androgen-deprivation therapy in prostate cancer and their management.Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance.Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners.Apigenin induces apoptosis by targeting inhibitor of apoptosis proteins and Ku70-Bax interaction in prostate cancer.Efficient Estimation of the Cox Model With Auxiliary Subgroup Survival Information.The landscape of systematic reviews in urology (1998 to 2015): an assessment of methodological quality.Intermittent versus continuous androgen deprivation therapy to biochemical recurrence after external beam radiotherapy: a phase 3 GICOR study.Comparison of intermittent and continuous androgen deprivation and quality of life between patients with locally advanced and patients with metastatic prostate cancer: a post hoc analysis of the randomized FinnProstate Study VII.Risks of Serious Toxicities from Intermittent versus Continuous Androgen Deprivation Therapy for Advanced Prostate Cancer: A Population Based Study.International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries.
P2860

Efficacy of intermittent androgen deprivation therapy vs conventional continuous androgen deprivation therapy for advanced prostate cancer: a meta-analysis

Item
http://www.wikidata.org/entity/Q34133868
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Efficacy of intermittent andro ...... ostate cancer: a meta-analysis
@ast
Efficacy of intermittent andro ...... ostate cancer: a meta-analysis
@en
Efficacy of intermittent andro ...... ostate cancer: a meta-analysis
@nl
type
label
Efficacy of intermittent andro ...... ostate cancer: a meta-analysis
@ast
Efficacy of intermittent andro ...... ostate cancer: a meta-analysis
@en
Efficacy of intermittent andro ...... ostate cancer: a meta-analysis
@nl
prefLabel
Efficacy of intermittent andro ...... ostate cancer: a meta-analysis
@ast
Efficacy of intermittent andro ...... ostate cancer: a meta-analysis
@en
Efficacy of intermittent andro ...... ostate cancer: a meta-analysis
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Efficacy of intermittent andro ...... ostate cancer: a meta-analysis
@en
P2093
P2860
P304
P31
P356
10.1016/J.UROLOGY.2013.01.078
P407
P433
P478
P50
P577
P698
P932